The essential context.
- An exercise-related biomarker does not automatically become an effective supplement.
- Mouse performance findings and human observations answer different questions.
- Long-term human safety cannot be inferred from a naturally occurring sequence.
Why it is described as an exercise-related peptide
MOTS-c attracts interest in endurance, body-composition and healthy-ageing discussions because it links mitochondrial signalling with metabolic research. It is often promoted as a way to imitate exercise or improve adaptation. Those phrases compress several very different kinds of evidence.
A molecule rising during exercise may be a response to the exercise rather than a treatment that reproduces it. Giving a supplied substance also creates a different exposure from the body's own local and circulating signal. A sporting claim has to test that difference rather than assume it away.
Three kinds of evidence should stay separate
Different levels of evidence answer different questions.
Cells
Mechanistic metabolic experiments
Animals
Intervention and physical-performance observations
Humans
Endogenous exercise-associated measurements
Next question
Direct intervention benefit and safety in humans
The foundational metabolic research
Lee and colleagues' 2015 Cell Metabolism paper described MOTS-c as a mitochondrial-derived peptide. Cell and mouse experiments linked it with metabolic regulation and protection against certain diet- or age-related disturbances. This established a research direction, not a human sports therapy.
A mouse model can identify a mechanism worth investigating. It does not establish the magnitude of an effect in a trained person, a useful performance benefit or a safe exposure in humans. Claims of guaranteed fat loss or endurance gain are therefore much stronger than this evidence.
What the 2021 exercise paper actually combined
Reynolds and colleagues' 2021 Nature Communications study combined mouse experiments with human exercise observations. MOTS-c administration improved some mouse physical-performance measures; the human arm examined exercise-associated changes in endogenous MOTS-c.
The distinction is central. Observing people's own peptide levels during exercise does not test whether giving them a separate MOTS-c product improves performance. The human observations should not be presented as an athlete supplementation trial simply because they appear in the same paper.
| Claim | Evidence | Limit |
|---|---|---|
| Exercise-related human signal | Observational measurements | Not exogenous treatment efficacy |
| Improved mouse performance | Animal intervention experiments | No quantified human athletic gain |
| Exercise substitute | A marketing interpretation | Training's effects are not reproduced by a biomarker |
A second human study adds useful caution
Von Walden and colleagues' 2021 Journal of Applied Physiology study compared acute endurance exercise, resistance exercise and a control condition. It reported a trend for circulating MOTS-c after endurance work rather than a clear general fitness marker.
This helps prevent a simplistic more-is-better reading. A biomarker's behaviour depends on the experiment and does not by itself measure athletic quality. A proper intervention trial would need verified material, appropriate controls and meaningful functional outcomes before a performance claim could be evaluated.
Potential advantages and health uncertainties
The potential scientific advantage is a new way to investigate muscle metabolism and stress adaptation. An established advantage for a person taking a supplied product is a different proposition. The studies here do not provide a dependable human estimate of extra endurance, quicker recovery or improved body composition.
Endogenous does not mean an external product is harmless. Relevant safety questions include systemic effects, interactions and consequences of repeated exposure, alongside identity and manufacturing quality. Small animal studies and short biomarker observations cannot determine rare or delayed human harms.
Why a training story can outrun its evidence
The combination of mitochondrial language and animal performance results can sound more complete than it is. A mechanism, a biomarker observation and an intervention result in another species are three separate pieces. Joining them is a hypothesis, not a completed clinical argument.
A personal report of improved stamina would also need to separate changes in training, pacing, sleep and expectations. Without a fair comparison and verified product, it cannot establish a compound-specific effect. A credible article should preserve these gaps rather than turn the diagram of a mechanism into proof.
Competition status and conclusion
WADA 2026: MOTS-c is prohibited at all times under S4.
The research is relevant to exercise biology, but relevance is not an established use indication. The most informative conclusion keeps the positive experimental findings visible while clearly distinguishing them from the unproven benefits and uncertain safety of supplied MOTS-c in athletes.
Frequently asked questions
Does the human exercise arm prove a benefit from taking MOTS-c?
No. It examined naturally occurring peptide changes rather than a performance-enhancement intervention.
Do mouse endurance results predict a human gain?
They justify further research but do not quantify a human effect or establish safety.
Sources & further reading
Follow the original publications and records behind this overview. Each source answers a specific question; no single record establishes every aspect of a compound or product.
- 01 Lee et al. (2015), Cell Metab: MOTS-c and metabolic homeostasis. PMID 25738459.
- 02 Reynolds et al. (2021), Nat Commun 12:470: MOTS-c and exercise biology.
- 03 von Walden et al. (2021), J Appl Physiol: exercise and circulating mitochondrial peptides. PMID 34351816.
- 04 WADA: 2026 List.
Dr. Monica Tatem
Dr. Monica Tatem earned her Ph.D. in Molecular Pharmacology from a leading medical university, followed by postdoctoral research focused on anabolic pathways and cellular signaling. Her scientific work encompasses a comprehensive...
View author profile